Outcomes of hospitalized patients with SARS-CoV-2 infection previously treated with renin-angiotensin system inhibitors

BACKGROUND: Renin angiotensin system inhibitors (RASi) are largely prescribed in hypertensive patients. As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) penetrates respiratory epithelium through angiotensin converting enzyme 2 (ACE2) binding, the association between RASi and poorer ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Cordeanu, E., Jambert, L., Lambach, H., Tousch, J., Heitz, M., Mirea, C., Frantz, A.S., Younes, W., Delatte, A., Woehl, B., Bilbault, P., Ohlmann, P., Meziani, F., Andres, E., Stephan, D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS 2021
Materias:
462
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803093/
http://dx.doi.org/10.1016/j.acvdsp.2020.10.143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7803093/
http://dx.doi.org/10.1016/j.acvdsp.2020.10.143

Ejemplares similares